Allurion Technologies Inc. (ALUR)

USD 0.31

(-1.65%)

Gross Profit Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual gross profit in 2023 was 41.49 Million USD , down -18.94% from previous year.
  • Allurion Technologies Inc.'s latest quarterly gross profit in 2024 Q1 was 6.7 Million USD , up 5.86% from previous quarter.
  • Allurion Technologies Inc. reported a annual gross profit of 50.72 Million USD in annual gross profit 2022, up 73.78% from previous year.
  • Allurion Technologies Inc. reported a annual gross profit of 29.19 Million USD in annual gross profit 2021, down 0.0% from previous year.
  • Allurion Technologies Inc. reported a quarterly gross profit of 8.9 Million USD for 2024 Q2, up 34.22% from previous quarter.
  • Allurion Technologies Inc. reported a quarterly gross profit of 13.96 Million USD for 2023 Q3, up 40.13% from previous quarter.

Annual Gross Profit Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Gross Profit of Allurion Technologies Inc. (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 41.49 Million USD -18.94%
2022 50.72 Million USD 73.78%
2021 29.19 Million USD 0.0%
2020 - USD 0.0%

Peer Gross Profit Comparison of Allurion Technologies Inc.

Name Gross Profit Gross Profit Difference
Abbott Laboratories 22.13 Billion USD 99.813%
Artivion, Inc. 229.17 Million USD 81.893%
Avanos Medical, Inc. 379.7 Million USD 89.071%
Butterfly Network, Inc. 16.85 Million USD -146.185%
Butterfly Network, Inc. 16.85 Million USD -146.185%
Bio-Rad Laboratories, Inc. 1.43 Billion USD 97.101%
Boston Scientific Corporation 9.89 Billion USD 99.581%
Perspective Therapeutics, Inc. 1.63 Million USD -2439.596%
CONMED Corporation 643.06 Million USD 93.547%
Edwards Lifesciences Corporation 4.62 Billion USD 99.103%
Paragon 28, Inc. 172.79 Million USD 75.984%
Glaukos Corporation 239.13 Million USD 82.647%
Globus Medical, Inc. 1.02 Billion USD 95.933%
Inspire Medical Systems, Inc. 528.22 Million USD 92.144%
Integer Holdings Corporation 418.28 Million USD 90.079%
Medtronic plc 19.45 Billion USD 99.787%
Nevro Corp. 290.06 Million USD 85.694%
Owlet, Inc. 22.58 Million USD -83.721%
Penumbra, Inc. 682.64 Million USD 93.921%
Vicarious Surgical Inc. -1.85 Million USD 2338.242%
Smith & Nephew plc 3.7 Billion USD 98.879%
Sonendo, Inc. 10.72 Million USD -287.027%
STERIS plc 2.23 Billion USD 98.142%
Stryker Corporation 13.05 Billion USD 99.682%
Vapotherm, Inc. 28.28 Million USD -46.721%
Zimmer Biomet Holdings, Inc. 5.31 Billion USD 99.219%